Get Permission Pandey, Dubey, Bhargava, Peswani, Khan, and Bhatt: Unlocking oral submucous fibrosis: From origin to interventions


Introduction

Oral Submucous Fibrosis (OSMF) is a chronic, progressive, and potentially malignant disorder of the oral cavity. It primarily affects the Indian subcontinent, Southeast Asia, and some Middle Eastern regions, although isolated cases have been reported worldwide. OSMF is characterized by fibrosis of the submucosal tissues, resulting in restricted mouth opening, burning sensations, and difficulties in eating and speaking. This debilitating condition not only impacts an individual's oral health but also poses a significant risk of malignant transformation, making it a matter of great concern for both patients and healthcare professionals.

Moreover, OSMF has far-reaching socioeconomic implications due to its impact on an individual's ability to consume a regular diet and the potential loss of productivity associated with the disease. It places a substantial burden on healthcare systems and necessitates a comprehensive approach encompassing prevention, early detection, and various treatment modalities.

In this comprehensive review article, we aim to provide an in-depth exploration of OSMF, delving into its origins, complexities, and the diverse range of interventions available to address this challenging oral disease. Additionally, we will discuss the psychosocial aspects of living with OSMF and the importance of patient education and support networks in coping with this condition. Furthermore, we will explore the latest advancements in research and emerging therapeutic approaches, offering hope for improved outcomes and a better quality of life for individuals affected by OSMF.1, 2

Areca Nut and Betel Quid Chewing

Areca nut and betel quid chewing represent the primary etiological factors in the development of Oral Submucous Fibrosis (OSMF). This practice is prevalent in many parts of the world, particularly in the Indian subcontinent, Southeast Asia, and some Middle Eastern countries. Areca nut is the seed of the Areca catechu palm tree and is widely consumed in various forms, often combined with betel leaves, slaked lime (calcium hydroxide), and sometimes tobacco.3

The most critical component in this concoction is the areca nut, which contains several alkaloids, with arecoline being the most notable. Arecoline is a psychoactive alkaloid that interacts with the cholinergic system and has been strongly implicated in the pathogenesis of OSMF. Its effects include vasoconstriction, increased collagen production, and fibroblast proliferation in the oral mucosa. This combination of factors leads to fibrosis, reduced blood supply, and eventually, the clinical manifestations of OSMF.

Furthermore, the inclusion of tobacco in betel quid chewing increases the risk of OSMF. Tobacco contains carcinogens and other harmful compounds that can exacerbate the inflammatory and fibrotic processes in the oral tissues. The synergistic effect of areca nut and tobacco significantly elevates the risk of developing OSMF and also increases the likelihood of malignant transformation within the oral cavity.

Genetic and Environmental Factors

While areca nut and betel quid chewing represent the primary external triggers for OSMF, genetic predisposition and various environmental factors can also play significant roles in its onset and progression.4

  1. Genetic predisposition: There is evidence to suggest that some individuals may have a genetic predisposition to OSMF. Those with a family history of the condition may be more susceptible to developing it themselves. Genetic factors may influence an individual's susceptibility to the toxic effects of areca nut and their ability to repair tissue damage caused by its consumption.

  2. Environmental factors: OSMF can also be influenced by environmental factors. These include dietary habits and nutritional deficiencies. Diets lacking in essential vitamins and minerals, especially iron and vitamin B complex, can contribute to the development of OSMF. Additionally, the consumption of spicy and hot foods, which can cause chronic irritation to the oral mucosa, may exacerbate the condition.

  3. Chronic irritation from dental fixtures such as ill-fitting dentures or orthodontic appliances can also contribute to the development of OSMF in susceptible individuals. The constant friction and pressure on the oral tissues can exacerbate the fibrotic process initiated by areca nut and betel quid consumption.

The etiology of OSMF is multifactorial, with areca nut and betel quid chewing being the most significant contributors. These substances contain alkaloids like arecoline, which induce fibrosis and carcinogenesis in the oral cavity. Genetic predisposition, dietary factors, and chronic irritation from various sources also play pivotal roles in the development of OSMF. Understanding these etiological factors is crucial for both prevention and management strategies aimed at mitigating the impact of this debilitating condition.

Pathogenesis5, 6

The pathogenesis of Oral Submucous Fibrosis (OSMF) is a complex and multifaceted process, involving a cascade of events that ultimately result in fibrosis and tissue damage within the oral mucosa. To gain a deeper understanding of the molecular mechanisms at play, let's examine the key factors involved in the pathogenesis of OSMF in detail:

  1. Inflammation: Chronic Inflammation: OSMF is triggered by chronic inflammation within the oral mucosa. This inflammation is primarily in response to the components of areca nut and betel quid, such as arecoline. Arecoline activates immune cells and initiates an inflammatory response. Over time, this persistent inflammation contributes to the development of OSMF.

  2. Fibrosis: Increased Collagen Deposition: One of the hallmark features of OSMF is the excessive deposition of collagen fibers in the submucosal tissues of the oral cavity. This fibrosis results from the continuous activation of fibroblasts, the cells responsible for producing collagen. Arecoline and other components in areca nut and betel quid stimulate fibroblasts to synthesize collagen at an abnormal rate. Alterations in the Extracellular Matrix: The extracellular matrix (ECM) provides structural support to tissues. In OSMF, the ECM undergoes significant alterations. There's an increase in collagen type I and III, as well as other fibrotic markers like fibronectin. These changes lead to the thickening and stiffening of the oral mucosa, which, in turn, restricts mouth opening and impairs normal oral function.

  3. Oxidative stress: Reactive Oxygen Species (ROS) Production: Areca nut and betel quid consumption is associated with the generation of reactive oxygen species, which are highly reactive molecules containing oxygen. ROS can cause oxidative stress, damaging cellular components like proteins, lipids, and DNA. In the context of OSMF, oxidative stress contributes to inflammation, apoptosis (cell death), and fibrosis.

  4. Changes in extracellular matrix: Increased Expression of Fibrotic Markers: The continuous exposure to areca nut components, particularly arecoline, leads to changes in gene expression within the oral mucosa. There's an upregulation of genes associated with fibrosis, including those involved in collagen production and tissue remodeling. These molecular changes further drive the fibrotic process.

Understanding these molecular mechanisms is of paramount importance for the development of effective interventions aimed at managing and preventing OSMF. Targeting key components of the pathogenesis, such as inflammation, oxidative stress, and fibrosis, can potentially help mitigate the progression of the disease. Research into novel therapeutic strategies, including drugs that modulate fibrotic markers or antioxidants to counter oxidative stress, is ongoing and holds promise for improving the prognosis and quality of life for individuals affected by OSMF. Additionally, early intervention and lifestyle modifications to reduce exposure to risk factors like areca nut and betel quid consumption are crucial in addressing OSMF at its root causes.

Clinical Features

Early signs7

  1. Burning sensation in the oral cavity, particularly after the consumption of irritants.

  2. Reduced mouth opening (trismus), which progresses over time.

  3. White fibrous bands in the oral mucosa, often initially on the buccal mucosa and the soft palate.

  4. Mucosal rigidity makes it difficult to move the tongue and cheeks.

Advanced stages8

  1. Severe trismus, sometimes to the point of being unable to open the mouth adequately.

  2. Atrophy of oral tissues, leading to the loss of normal oral architecture.

  3. Potentially malignant changes, such as leukoplakia (white patches) and erythroplakia (red patches).

Diagnostic approaches9

  1. Diagnosis of OSMF typically involves clinical evaluation by an oral healthcare professional. However, additional tests and assessments may be required:

Biopsy

  1. Tissue sampling to confirm the presence of fibrosis and rule out malignancy.

Histopathological examination

  1. Microscopic evaluation to assess the severity of fibrosis and inflammation.

Imaging studies9

  1. Radiographic examinations like MRI and CT scan to visualize the extent of fibrotic changes.

  2. Early detection is critical for better outcomes, as it allows for timely intervention.

Interventions

Management10

  1. Management strategies for OSMF encompass a multifaceted approach:

  2. Quitting areca nut and betel quid consumption: The most crucial step in halting disease progression.

  3. Dietary modifications: Recommending soft, non-irritating foods to ease discomfort during meals.

  4. Medications: Pharmacological interventions may include corticosteroids, antioxidants, and collagenase injections to reduce fibrosis and inflammation.

  5. Physiotherapy: Exercises and stretches to improve mouth opening and maintain oral function.

  6. Surgical interventions: Reserved for severe cases, such as the release of fibrotic bands to improve mouth opening.

Prevention11

  1. Preventing OSMF is a complex endeavor that requires a combination of public health measures and individual actions:

  2. Public awareness campaigns: Educating the public about the risks associated with areca nut and betel quid consumption.

  3. Regulation: Enforcing laws and regulations on the sale and distribution of these substances.

  4. Tobacco cessation programs: Providing support for individuals trying to quit addictive habits.

Emerging therapies12, 13, 14, 15 (12-15)

Researchers are actively exploring various innovative approaches to address the fibrotic changes and potentially malignant nature of OSMF:

Stem cell therapy

  1. Investigating the potential of stem cells to regenerate damaged oral tissues.

Growth factors

  1. Administering growth factors to promote tissue healing and regeneration.

Targeted molecular therapies

  1. Developing drugs that specifically target fibrosis-related pathways.

Conclusion

Oral submucous fibrosis is a complex and challenging oral condition with significant public health implications. Understanding its origins, pathogenesis, clinical features, and available interventions is crucial for early detection, management, and prevention. Ongoing research into emerging therapies holds promise for improving the prognosis of OSMF and reducing its global burden.

This comprehensive review article serves as a valuable resource for healthcare professionals, researchers, and policymakers working toward addressing the multifaceted aspects of OSMF, from its origin to effective interventions, and underscores the importance of a holistic approach to its management and prevention.

Source of Funding

None.

Conflict of Interest

None.

References

1 

D Passi P Bhanot D Kacker D Chahal M Atri Y Panwar Oral submucous fibrosis: Newer proposed classification with critical updates in pathogenesis and management strategiesNatl J Maxillofac Surg2017828994

2 

K Chaudhry R Bali AK Patnana C Chattopadhyay PP Sharma S Khatana Impact of Oral Submucous Fibrosis on Quality of Life: A Multifactorial AssessmentJ Maxillofac Oral Surg20201922516

3 

SK Bansal S Leekha D Puri Biochemical changes in OSMFJ Adv Med Dent Sci201311015

4 

RV Prabhu V Prabhu L Chatra P Shenai N Suvarna S Dandekeri Areca nut and its role in oral submucous fibrosisJ Clin Exp Dent20146556975

5 

YH Shih TH Wang TM Shieh YH Tseng Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and TherapyInt J Mol Sci201920122940

6 

YW Shen YH Shih LJ Fuh TM Shieh Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and TreatmentsInt J Mol Sci202021197231

7 

FM Ali A Patil K Patil MC Prasant Oral submucous fibrosis and its dermatological relationIndian Dermatol Online J2014532605

8 

NK Das AKM Kadir MU Shemanto E Akhter A Sharfaraz S Tripura Genetic Revelation of the Potentially Malignant Disorders in the Oral and Maxillofacial RegionPopulation Genetics - From DNA to Evolutionary BiologyIntechOpenRijeka2023

9 

NR Rao A Villa CB More RD Jayasinghe AR Kerr NW Johnson Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical managementJ Otolaryngol Head Neck Surg202049310.1186/s40463-020-0399-7

10 

SC Cox DM Walker Oral submucous fibrosis: a reviewAust Dent J1996412949

11 

S Warnakulasuriya AR Kerr Oral submucous fibrosis: a review of the current management and possible directions for novel therapiesOral Surg Oral Med Oral Pathol Oral Radiol2016122223241

12 

H Xu FY Lyu JY Song YM Xu EH Jiang ZJ Shang Research Achievements of Oral Submucous Fibrosis: Progress and ProspectBiomed Res Int202120216631856

13 

F Lin T Xiao B Wang L Wang G Liu R Wang Mechanisms and markers of malignant transformation of oral submucous fibrosisHeliyon2024101e23314

14 

GN Suma MP Arora M Lakhanpal Stem cell therapy: A novel treatment approach for oral mucosal lesionsJ Pharm Bioallied Sci20157128

15 

X Qin Y Ning L Zhou Y Zhu Oral Submucous Fibrosis: Etiological Mechanism, Malignant Transformation, Therapeutic Approaches and TargetsInt J Mol Sci20232454992



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 26-08-2023

Accepted : 04-10-2023


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.jooo.2023.040


Article Metrics






Article Access statistics

Viewed: 707

PDF Downloaded: 206



Medical Abbreviation List